EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Mechanistic analysis on epigenetic programming of tumor drug resistance

Xiao-Xiao Han, Kun Pang, Jia-Hao Sun, Yu-Fei Lou, Zhen-Yuan Zhang, Jiang-Shang Bao, Yi Yu, Xing Liu, Jian-Quan Hou, Ying Liu, Zhen-Duo Shi

Drug Resistance Updates · 2026-09 · 88 · 101441

DOI: 10.1016/j.drup.2026.101441 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Resistance Updates, 2026-09. Verfasst von Xiao-Xiao Han und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Fourth Affiliated Hospital of Soochow University, Soochow, China. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Epigenesis, Genetic, Neoplasms, Antineoplastic Agents. Die Arbeit nennt 220 Literaturangaben. Gefördert von: Beijing Xisike Clinical Oncology Research Foundation, Xuzhou Medical University, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug resistance remains a critical clinical bottleneck restricting long-term curative efficacy of chemo-, targeted, and other therapies against human malignancies. Drug-tolerant persister (DTP) cancer cells and intratumoral heterogeneity substantially compromise therapeutic responses and worsen patient clinical prognosis. This review summarizes core epigenetic regulatory mechanisms of drug resistance, including DNA methylation, histone modifications, non-coding RNAs (ncRNAs), N⁶-methyladenosine (m⁶A) RNA methylation, and metabolism-epigenetic crosstalk axis, elaborating the mechanistic links between epigenetic programming and the acquisition of tumor drug resistance. The dynamic epigenetic alterations remodel aberrant transcriptional landscapes to empower cancer cells to circumvent cytotoxic drug elimination. Distinct from irreversible genomic mutations, epigenetic modifications are pharmacologically reversible; such biological plasticity enables combinatorial regimens pairing epigenetic modulators with conventional cytotoxic agents as a viable strategy to reverse therapeutic resistance. In-depth dissection of the epigenetic regulatory networks facilitates identification of novel epigenetic biomarkers and druggable targets, providing rationale for developing personalized combination therapies and ultimately improving clinical outcomes of drug-resistant cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmEpigenesis, GeneticNeoplasmsAntineoplastic AgentsHumansDNA MethylationGene Expression Regulation, NeoplasticRNA MethylationHistonesAnimalsRNA, Untranslated

Stichwörter der Autor:innen

BiomarkersDrug resistanceEpigeneticsTherapeutic targets

Substanzen

Antineoplastic AgentsHistonesRNA, Untranslated

Autor:innen und Institutionen

  • Department of Urology, The Fourth Affiliated Hospital of Soochow University, Soochow, China.
  • Department of Urology, Xuzhou Central Hospital, Southeast University, Xuzhou, Jiangsu, China.
  • Department of Urology, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Jiangsu Provincial Engineering Research Center of Cancer Cell Therapy and Translational Medicine, Xuzhou Central Hospital, Southeast University, Xuzhou, Jiangsu, China.
  • Department of Urology, The Fourth Affiliated Hospital of Soochow University, Soochow, China. Electronic address: houjianquan@suda.edu.cn.
  • Jiangsu Provincial Engineering Research Center of Cancer Cell Therapy and Translational Medicine, Xuzhou Central Hospital, Southeast University, Xuzhou, Jiangsu, China. Electronic address: liuy0410@163.com.

Förderung

  • Beijing Xisike Clinical Oncology Research Foundation
  • Xuzhou Medical University
  • Natural Science Foundation of Jiangsu Province
  • Jiangsu Commission of Health

Zitieren

APA

Han, X. X., Pang, K., Sun, J. H., Lou, Y. F., Zhang, Z. Y., Bao, J. S., Yu, Y., Liu, X., Hou, J. Q., Liu, Y., & Shi, Z. D. (2026). Mechanistic analysis on epigenetic programming of tumor drug resistance. Drug Resistance Updates, 88, 101441. https://doi.org/10.1016/j.drup.2026.101441

Vancouver

Han XX, Pang K, Sun JH, Lou YF, Zhang ZY, Bao JS, et al. Mechanistic analysis on epigenetic programming of tumor drug resistance. Drug Resistance Updates. 2026;88:101441. doi:10.1016/j.drup.2026.101441

BibTeX
@article{Han2026,
  author = {Han, Xiao-Xiao and Pang, Kun and Sun, Jia-Hao and Lou, Yu-Fei and Zhang, Zhen-Yuan and Bao, Jiang-Shang and Yu, Yi and Liu, Xing and Hou, Jian-Quan and Liu, Ying and Shi, Zhen-Duo},
  title = {Mechanistic analysis on epigenetic programming of tumor drug resistance},
  journal = {Drug Resistance Updates},
  year = {2026},
  volume = {88},
  pages = {101441},
  doi = {10.1016/j.drup.2026.101441}
}
Kostenlos starten →